Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0017638 (glioma)
 30,880 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Coronal computed tomography findings in 30 cases of skull and brain diseases, including glioma 6 cases, meningioma 4 cases, acoustic neurinoma 3 cases, intraorbital tumor 3 cases, paranasal sinus tumor 3 cases, pituitary adenoma 2 cases, craniopharyngioma 2 cases, nasopharyngeal carcinoma 2 cases, empty sella 1 case, subdural hematoma 1 case, infarction 1 case, subarachnoid cyst 1 case, and metastasis 1 case are reported. The results show that as an adjunct to the axial computed tomography coronal CT scan provides valuable additional diagnostic informations. Coronal CT methods are also discussed.
 ...
PMID:[Diagnostic evaluation of coronal CT scan in skull and brain diseases]. 259 38

Progressive brainstem and cerebellar signs developed in a previously healthy 70-year-old man over a course of seven days. A pontine mass characterized by CT and MRI suggested an infiltrating primary pontine glioma. Gross postmortem examination showed a medullary-pontine hemorrhage. Microscopic analysis disclosed an undifferentiated large cell carcinoma which was found to originate from the lung. Differential diagnoses in cases of suspected brainstem lesions are given, including metastatic tumors which are rare when presenting as a solitary brainstem mass. Optimal patient management should be formulated on the basis of histopathological diagnosis rather than imprecise imaging data. Exact tissue diagnosis will also avoid an extensive and expensive search for an occult systemic cancer. The roles of radiation, chemotherapy and surgery are also discussed.
 ...
PMID:Fatal pontine metastasis: clinical, CT, MRI and pathological correlates. 261 50

Human glioma (U-118 MG and U-138 MG), human colorectal adenocarcinoma (HT-29), human thyroid carcinoma (HTh 7), and hamster embryonic lung (V79-379A) spheroids were irradiated with either single doses of 16 or 40 Gy or fractionated doses of eight times 5 Gy. Oxygen profiles in the spheroids were measured with microelectrodes at different times following irradiation, and these profiles were then compared with the oxygen profiles measured in parallel cultured nonirradiated spheroids. No significant radiation-induced changes in the oxygen profiles were seen in any of the spheroids within the first few days after irradiation. The glioma spheroids did not show any significant increase in oxygen tension even after longer times; however, they were growth inhibited, and the number of S-phase cells was strongly suppressed. Increases in oxygen tension did occur in the HT-29 and V79-379A spheroids but only appeared more than a week after irradiation, when degeneration had started. Histological changes and decrease in diameter were seen in the spheroids that started to degenerate about 5 days after irradiation. Thus radiation doses in the therapeutic range did not, for the spheroids studied, produce rapid increases in the oxygen tension. When a change occurred, it appeared rather late and was probably a consequence of cell degeneration.
 ...
PMID:Influence of ionizing radiation on oxygen profiles in different types of multicellular spheroids. 261 39

7878 patients with tumors in the head and neck confirmed by pathology from Jan. 1961 to Dec. 1981 are analysed. In this series, there were 5485 malignant tumors and 2393 benign. In malignant tumors, the ratio of male to female was 2.84:1 while the mean age incidence was 53.38 years. Nearly half of malignant tumors were in the nasopharynx (49.32%). Of the 2716 nasopharyngeal malignant tumors, 2698 were carcinoma and only 18 sarcoma. Male was 3.5 times higher than female. The mean age of NPC was 53.64 years in male and 52.33 years in female. Nine of them were under 10 years of age and the youngest was 3 years old. There was 87.06% of squamous cell carcinoma in NPC. Adenocarcinoma was predominant in the minor salivary gland carcinomas. The malignant tumors in the eyeball were glioma retinae of which 96.15% was under 10 years of age. The common metastatic tumor in the neck was squamous cell carcinoma. The incidence of head and neck tumors was 37.66% and that of the head and neck malignancies was 26.22% of tumors in the whole body. This study indicates that the incidence of malignant tumor in the head and neck is rather high.
 ...
PMID:[Analysis of 7878 patients with tumors in the head and neck]. 262 11

Ninety-one patients with parasellar lesions proved by pathology and surgery from July 1982 to May 1987 and 22 patients misdiagnosed clinically or by CT are reported. The authors found that: 1. Besides the main group of parasellar lesions such as pituitary tumor, meningioma, and craniopharyngioma, some rare disease like glioma, pituitary carcinoma, chordoma, olfactory neuroblastoma, Rathke's pouch and tuberculoma of optic nerve were also found which comprised 12% (11/91) in this series. They should be considered in differential diagnosis; 2. Correct diagnosis was made when CT findings conformed well with the clinical features. Over-emphasis of clinical features or neglect of CT findings should be discouraged as they may lead to erroneous diagnosis; 3. In this series, the highest correct diagnosis rates were: pituitary tumor (95%), parasellar meningioma (78%) and craniopharyngioma (50%). It is difficult to make a correct diagnosis for these rare disease entities before operation; and 4. CT scan cannot completely replace angiography and ventriculography when they are needed for differential diagnosis.
 ...
PMID:[CT scan and clinical diagnosis of parasellar lesions--analysis of 91 cases]. 262 13

Preproenkephalin A (PPA) mRNA expression was studied by Northern blot and in situ hybridization in cell lines (rat glioma C6, rat hepatoma HTC, human neuroblastoma IMR32, mouse neuroblastoma NS20Y, rat fibroblast FR3T3, human bladder carcinoma EJ, human vulva carcinoma A431, myelocytic leukemia HL60, rat adrenal carcinoma Y1) and in brain tumours (implanted C6 cells). C6 glioma in cell culture, as well as in brain tumours, expressed high levels of PPA mRNA as compared to the caudate nucleus of the rat brain. EJ and FR3T3 cell lines also expressed the PPA mRNA, which was not detectable in A431, Y1, NS20Y, IMR32, HTC, HL60 cell lines as well as in the rat liver. This observation provides an interesting model to study the mechanisms by which the malignant transformation can induce in glial cells the derepression of a gene which is usually expressed in neurons or in neuron-like cells.
 ...
PMID:Expression of the preproenkephalin A gene in tumor cells and brain glioma: a northern and in situ hybridization study. 273 83

The contents of 14 cysts that were located within human intracranial tumors were obtained at surgery by needle aspiration. These tumor cyst fluids (TCFs) were mostly derived from glial tumors (10 cases). TCFs from one metastasis from a mammary carcinoma, one cystic meningioma, one hemangioblastoma, and a cystic acoustic neurinoma were also included. These TCFs were added to primary cultures of human gliomas, established human glioma cell lines, and normal human arachnoid cells in culture. The presence of proliferation-promoting factors in all cyst fluids could be demonstrated. On the basis of the response patterns of the cultures, it was possible to distinguish different levels of growth autonomy and growth factor sensitivity among these cultures and to speculate about varying degrees of cellular autocrine activation. The TCFs appear to contain factors that are not normally present in fetal calf serum, which is a regular constituent of most cell culture media. Some primary cultured cells as well as cell lines react in an oversensitive manner to the addition of TCFs.
 ...
PMID:Cyst fluids of malignant human brain tumors contain substances that stimulate the growth of cultured human gliomas of various histological type. 277 Sep 84

The feasibility of 2-deoxy-2-[18F]fluoro-D-galactose ([ 18F]FdGal) for imaging galactose metabolism in tumors with positron emission tomography (PET), was investigated using two hepatomas, Yoshida sarcoma, or glioma in rats, and mouse mammary carcinoma. In hepatoma-bearing rats the highest uptake of [18F]FdGal was observed in the liver followed by the kidney and tumor. The tumor uptake increased with time, and the high uptake ratios of tumor to organ were observed except for the liver and kidney. Tumor uptake was also measured in all tumors. As main metabolites in all tumors, [18F]FdGal 1-phosphate and UDP-[18F]FdGal were found by HPLC. Two hepatomas showed a slightly higher uptake and a larger percentage of UDP derivative than the other three tumors. By autoradiography the brain tumor was visualized clearly. These results indicate that [18F]FdGal has potential as a tracer for imaging galactose metabolism in tumors with PET.
 ...
PMID:2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography. 278 12

Various authors have reported the incidence of the solitary metastatic lesion to range from 25-85% of cases with known cerebral metastasis. In about 20% of these cases, no primary neoplasm is ever identified. The therapeutic alternatives considered depend to a great extent on the histopathology of the tumour. Unfortunately, the difficulty of making a correct diagnosis in this setting is compounded by all of the problems associated with tumour sampling, i.e. the representativeness of the sample, the often miniscule amounts of tissue obtained, mechanical deformation of the sample, etc. This study describes the use of a monoclonal antibody panel in the immunophenotyping of 45 tumours where the differential diagnosis was glioma versus metastatic tumour with no known primary site. The monoclonal antibodies used bound neuroectodermal antigens (UJ13A), cytokeratin (LE61), and epithelial membrane antigens (AUA1), as well as human milk fat globule antigens (HMFG1, HMFG2). The neuroectodermally-derived MAB UJ13A accurately and reproducibly differentiated gliomas and metastatic lesions with one exception. Oat cell carcinomas (n = 5) were positive for both UJ13A and cytokeratin (LE61). There were no cases in which metastatic tumours were positive for UJ13A and negative for cytokeratin. A combination of the LE61 and AUA1 MABs resulted in positive staining in 44/45 (98%) cases. Immunophenotyping made a substantial contribution in 13 cases (29%), and in three cases the MAB panel was responsible for the final diagnosis. The antibody panel described in this study enables primary CNS neoplasms to be accurately distinguished from nonlymphoid metastatic tumours. In addition, a positive diagnosis of carcinoma is made in 98% cases, although identification of the precise organ of origin is not generally possible.
 ...
PMID:Monoclonal antibody immunophenotyping of solitary cerebral metastases with unknown primary sites. 281 51

The local use of radionuclides in the management of neoplastic processes was initially considered over 80 yr ago and has enjoyed increasing enthusiasm in the treatment of somatic and central nervous system tumours during the past 30 yr. The marriage of complex neuroimaging techniques and modern stereotactic devices has markedly enhanced the technical precision of interstitial radiobrachytherapy of malignant cerebral neoplasms. In applying these techniques, it is imperative to achieve an optimal placement of radionuclide sources in order to develop a geometrically homogenous, controlled distribution of radiation. Critical considerations include determination of tumour volume and contour, and development of a homogenous dose rate (dependent upon multiple sources at varying intensity) that will not only effect tumour cell kill but do this without excessive production of radionecrosis which necessitates craniotomy because of mass. Using the Brown-Roberts-Wells (BRW) stereotactic guidance system and an image-defined, volumetrically determined target, implants of multiple iridium 192(192Ir) sources were used to establish appropriate isodose envelopes. A methodology for achieving the described objectives is detailed as it applies to a variety of malignant intracerebral neoplasms (glioblastoma multiforme, malignant astrocytoma, malignant mixed glioma, primary cerebral lymphoma, metastatic carcinoma and malignant pineal region tumours). Technical realization of precision implantation relying upon imaging data may be acheived with this method with satisfactory responses that are dependent upon histological tumour type and the morphology of the tumour distribution as related to the image. Early and late complications related to the surgical technique and radionuclide applications were less than 5%. Although encouraging, these techniques require further definition and greater data accrual before uniform application outside major medical centres can be justified. It is anticipated that improvement in results with intrinsic gliomas and other invasive neoplasms will be realized with further definition of tumour boundaries by tract biopsy techniques and concurrent utilization of hyperthermia and brain protective methods.
 ...
PMID:Interstitial radiobrachytherapy of malignant cerebral neoplasms: rationale, methodology, prospects. 288 48


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>